Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

July 10, 2020 BIZ People

ReNetX’s Smith joins BioCT board

PHOTO | Contributed Erika Smith

Erika Smith, CEO of New Haven’s ReNetX Bio, has joined the board of directors at BioCT, the state’s bioscience advocacy organization.

ReNetX is a clinical-stage, venture-funded bioscience company that is working on a treatment to reverse spinal cord injury. Prior to leading ReNetX, Smith has held key executive roles at leading life-science companies including Respironics (Philips Healthcare), Hyperion and IVAX, BioCT said.

She also launched and led the advancement of three successful investment funds, including the $25 million Blavatnik Fund for Innovation at Yale, the Yale Entrepreneurial Institute Innovation Fund and the Bio-Life Fund at the Center for Innovative Technology in partnership with Johnson & Johnson.

Smith was highlighted in New Haven Biz’s special Innovators & Entrepreneurs publication in September 2019.  

Sign up for Enews

Most Recent

Most Recent

0 Comments

Order a PDF